je.st
news
Tag: merck
Merck Updates Plans for Headquarters Move in New Jersey
2013-10-01 14:30:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. Company to Close Summit Campus; Move Global HQ to Kenilworth WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced plans to move its global headquarters from Whitehouse Station, N.J., to its existing facilities in Kenilworth, N.J. The company had previously announced that it would close its Whitehouse Station building and relocate its global headquarters to Summit, N.J. Language: English Contact: MerckMedia:Lainie Keller, 908-423-4187Kelley Dougherty, 908-423-4291Investor:Carol Ferguson, 908-423-4465Joe Romanelli, 908-423-5185 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Merck Announces Global Initiative to Sharpen Commercial and R&D Focus
2013-10-01 13:30:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. Company Redesigns Operating Model; Reduces Cost Base Initiative targets net reduction in annual operating expenses of approximately $2.5 billion by the end of 2015 Plan includes new workforce reductions of approximately 8,500 positions, in addition to pending, previously announced reductions Company reaffirmed 2013 full-year non-GAAP EPS target of $3.45 to $3.55; revised GAAP EPS range to $1.58 to $1.82 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced a global initiative to sharpen its commercial and research and development (R&D) focus. The multi-year initiative will enable Merck to better target its resources behind those opportunities that have the potential to deliver the greatest return on investment, including bolstering its pipeline and implementing a more agile operating model, with a significantly reduced, more flexible cost structure. Language: English Contact: MerckMedia Contacts:Kelley Dougherty, 908-423-4291Steven Cragle, 908-423-3461orInvestor Contacts:Carol Ferguson, 908-423-4465Joe Romanelli, 908-423-5185 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: global
commercial
focus
initiative
Merck Unveils Meoxal Taklamakan Gold
2013-09-30 07:00:00| Coatings World Breaking News
Merck to Hold Third-Quarter 2013 Sales and Earnings Conference Call on October 28
2013-09-27 14:30:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2013 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Monday, Oct. 28. During the call, company executives will provide an overview of Mercks performance for the quarter. Language: English Contact: MerckMedia Contacts:Kelley Dougherty, 908-423-4291Steven Cragle, 908-423-3461orInvestor Contacts:Carol Ferguson, 908-423-4465Joe Romanelli, 908-423-5185 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Merck says FDA won't approve Bridion
2013-09-23 18:36:57| Biotech - Topix.net
Bridion, or sugammadex, is used to reverse the effects of anesthesia after surgery.
Tags: approve
fda
merck
fda merck
Sites : [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] next »